Form 4 for TDOC Teladoc Health, Inc.
Accepted 2024-06-04 00:00:00 ET · period of report 2024-05-31 · accession 0001477449-24-000145 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-04 | 2024-06-03 | TDOC | Vandervoort Adam C | CLO, Sec | S - Sale+OE | $11.16 | -4,015 | 41.3K | -9% | -$44.8K |
| DM | 2024-06-04 | 2024-05-31 | TDOC | Vandervoort Adam C | CLO, Sec | M - OptEx | — | +7,803 | 40.9K | +24% | — |
| DM | 2024-06-04 | 2024-05-31 | TDOC | Vandervoort Adam C | CLO, Sec | M - OptEx | $0.00 | -7,803 | 30.9K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-03 | S | D | 4,015 | $11.16 | 41,264 | D | — | — | (F3) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| 2 | Common | Common Stock | 2024-05-31 | M | A | 4,417 | — | 45,279 | D | — | — | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 3 | Common | Common Stock | 2024-05-31 | M | A | 1,505 | — | 38,981 | D | — | — | (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 4 | Common | Common Stock | 2024-05-31 | M | A | 1,881 | — | 40,862 | D | — | — | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 5 | Derivative | Performance Stock Units | 2024-05-31 | M | D | 1,505 | $0.00 | 10,540 | D | — · — to — | 1,505 Common Stock | (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. (F4) On March 1, 2024, the reporting person earned 18,067 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 6 | Derivative | Restricted Stock Units | 2024-05-31 | M | D | 1,881 | $0.00 | 5,643 | D | — · — to — | 1,881 Common Stock | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F5) On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 7 | Derivative | Restricted Stock Units | 2024-05-31 | M | D | 4,417 | $0.00 | 30,925 | D | — · — to — | 4,417 Common Stock | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F6) On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |